Wang Jing, Jia Qi, Xiang Haoyu, Wang Fang, Sun Chao, Chang Jitao, Jiang Zhigang, Yin Xin
State Key Laboratory for Animal Disease Control and Prevention, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, China.
TERRA Teaching and Research Center, Gembloux Agro-Bio Tech, University of Liège, Liège, Belgium.
Front Cell Infect Microbiol. 2025 Jul 14;15:1633030. doi: 10.3389/fcimb.2025.1633030. eCollection 2025.
Schmallenberg virus (SBV) is an emerging orthobunyavirus transmitted by midges. It poses a serious global health threat to ruminants, especially during pregnancy, causing abortion, stillbirths, and congenital malformations. Since its first outbreak in 2011, SBV has spread across Europe and other regions. Its transmission has expanded due to global climate change and increased animal trade, resulting in recurrent outbreaks in endemic regions and a growing risk of introduction into non-endemic areas. This situation highlights the urgent need for improved control strategies. This review summarizes the pathogenic and epidemiological characteristics of SBV and provides an overview of recent advancements in diagnostic approaches, vaccine development, and vector control. Diagnostic approaches, such as serological assays and nucleic acid-based tests, have become the primary tools for SBV detection. However, their applicability in clinical settings still requires further optimization. In terms of vaccine development, existing inactivated vaccines have limitations, including the inability to distinguish between vaccinated and infected animals. This has driven the development of next-generation vaccines, such as recombinant protein, viral vector, and mRNA-based platforms. For vector control, integrated approaches combining chemical, ecological, and biological strategies have been proposed to interrupt the transmission of the virus by midges. Additionally, this review emphasizes the necessity of region-specific control strategies tailored to the differing epidemiological contexts. In endemic regions, comprehensive measures, including pathogen surveillance, vaccination programs, and control, are critical. In non-endemic regions, the focus should be on enhancing border biosecurity, monitoring international trade, and establishing early warning systems. These strategies not only provide a scientific foundation for SBV control but also offer practical guidance for managing the spread of similar vector-borne viruses globally.
施马伦贝格病毒(SBV)是一种由蠓传播的新型正布尼亚病毒。它对反刍动物构成严重的全球健康威胁,尤其是在怀孕期,会导致流产、死产和先天性畸形。自2011年首次爆发以来,SBV已在欧洲和其他地区传播。由于全球气候变化和动物贸易增加,其传播范围不断扩大,导致流行地区疫情反复爆发,传入非流行地区的风险也日益增加。这种情况凸显了改进防控策略的迫切需求。本综述总结了SBV的致病和流行病学特征,并概述了诊断方法、疫苗研发和病媒控制方面的最新进展。血清学检测和基于核酸的检测等诊断方法已成为检测SBV的主要工具。然而,它们在临床环境中的适用性仍需进一步优化。在疫苗研发方面,现有的灭活疫苗存在局限性,包括无法区分接种疫苗的动物和感染病毒的动物。这推动了下一代疫苗的研发,如重组蛋白、病毒载体和基于mRNA的平台。对于病媒控制,已提出结合化学、生态和生物策略的综合方法,以阻断蠓传播病毒。此外,本综述强调了根据不同流行病学背景制定区域特异性控制策略的必要性。在流行地区,包括病原体监测、疫苗接种计划和病媒控制在内的综合措施至关重要。在非流行地区,重点应放在加强边境生物安全、监测国际贸易和建立预警系统上。这些策略不仅为控制SBV提供了科学依据,也为全球管理类似病媒传播病毒的传播提供了实际指导。